Ignite Creation Date:
2025-12-24 @ 2:28 PM
Ignite Modification Date:
2025-12-27 @ 12:07 AM
Study NCT ID:
NCT00927459
Status:
TERMINATED
Last Update Posted:
2010-01-22
First Post:
2009-06-23
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Liposomal siRNA in Subjects With High Cholesterol
Sponsor:
Arbutus Biopharma Corporation
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
TKM-ApoB-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Mark Murray, PhD, CEO
Old Organization:
Tekmira Pharmaceuticals Corporation